Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor
M. Teresa Magone, Iris R. Hartley, Edmond J. FitzGibbon, Rachel Bishop, Mike Arango, Susan Moran, Roo Vold, Jaydira Del Rivero, Karen Pozo, Jamie Streit, Kelly L. Roszko, Michael T. Collins, Rachel I. Gafni
Topics & Concepts
Fibroblast growth factor receptorFibroblast growth factor receptor 1MedicineCancer researchTyrosine kinaseReceptor tyrosine kinaseFibroblast growth factor receptor 2Fibroblast growth factor 23Growth factor receptorFibroblast growth factorInternal medicineReceptorCalciumParathyroid hormoneFibroblast Growth Factor ResearchIgG4-Related and Inflammatory DiseasesHistiocytic Disorders and Treatments